Westfield Imaging Center - Summit Radiological Associates, P.A. Enhancing the Health of Our Patients
About Bone Densitometry/DXA Scans

Osteoporosis is responsible for more than 1.5 million fractures annually in the United States. Half of women over the age of 50 will have an osteoporosis-related fracture in their lifetime.

Osteoporosis affects nearly one-half of all postmenopausal women, the largest group at high risk for osteoporosis. Bone Densitometry safely, accurately, and painlessly measures bone density and mineral content in order to determine the risk of developing osteoporosis.

Westfield Imaging Center proudly employs a state-of-the-art bone densitometer. This highly sensitive densitometer identifies bone loss at the major fracture sites, such as the femur and spine.

Bone Densitometry/DXA is a fast, safe, and painless test that uses advanced technology called Dual-Energy X-Ray Absorptiometry to measure bone density and determine the risk of developing osteoporosis.

Your physician will determine whether treatment is needed based on the results of this test. If you are undergoing treatment, the scan monitors the effects of therapy.

Until now, evaluating bone density using conventional x-ray systems did not reveal a potential problem until a patient had lost 25-30 percent of her bone density. Now, in just 30 seconds, our highly sensitive densitometer identifies risk at a much earlier stage.

Risk Factors

  • Family history of osteoporosis
  • Early menopause
  • Prolonged use of steroids
  • Fractures after age 50
  • Low calcium and vitamin D intake
  • Small, thin-framed body
  • Alcohol abuse
  • Cigarette smoking
  • High levels of caffeine intake
  • Prolonged bed rest or sedentary lifestyle

Who Should Be Tested

  • All women over age 65.
  • All post menopausal women under 65 with risk factors.
  • Men aged 70 and older.
  • Adults with a fragility fracture.
  • Adults with a disease or condition associated with low bone mass or bone loss.
  • Adults taking medications associated with low bone mass or bone loss.
  • Anyone being considered for pharmacologic therapy.
  • Anyone being treated; to monitor treatment effect.